Advances in Nanoparticle-Based Therapeutics
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Nanoscience".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 4334
Special Issue Editor
Interests: nanoparticles; radiation; radiotherapy; radiology; dose; radio-sensitisation; ionising radiations; theranostic; radiobiology; non-ionising radiation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Novel functional nanomaterials have become a new research hotspot in the field of medical treatment strategies. Its outstanding advantages are increasingly valued by the medical community, especially in the field of cancer and inflammation treatment. The combination of nanotechnology and biomedicine has provided a new way of thinking for the medical community. The properties of nanoparticles, such as small diameter, large specific surface area, and sensitivity to the surrounding environment, enable them to play a targeted role in tumor imaging and therapy. Using nanomaterials as drug delivery systems can also improve the absorption and utilization of drugs, achieve efficient targeted delivery, prolong drug half-life, and reduce toxic side effects to normal tissues.
This special issue aims to collect relevant research on nanoparticle-based therapy, including but not limited to the following topics:
- Nano Biomedical Materials;
- Nanoparticle photothermal therapy;
- Novel Nano-drug Delivery System;
- Applications of Magnetic Nanoparticles.
Dr. Moshi Geso
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticle
- gold nanoparticles
- nanoparticle-based photothermal therapy
- magnetic nanoparticles
- biomimetic nano-drug carrier system
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.